SHL TeleMedicine has presented initial data from two clinical trials of its SmartHeart, showing a reduction in hospital visits in post-myocardial infarction (MI) patients.
The results are from two clinical trials, HELP-MI and TELE-ACS, which are being conducted at the Mayo Clinic (US) and the Imperial College London (UK), respectively. The data was first presented at the Vulnerable Plaque and Patient Meeting (VPM) 2023 on 20 September.
